United States v. Joseph Newbold

686 F. App'x 181
CourtCourt of Appeals for the Fourth Circuit
DecidedApril 25, 2017
Docket16-4013
StatusUnpublished

This text of 686 F. App'x 181 (United States v. Joseph Newbold) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Joseph Newbold, 686 F. App'x 181 (4th Cir. 2017).

Opinion

Unpublished opinions are not binding precedent in this circuit.

*183 GREGORY, Chief Judge:

In September 2005, Joseph Newbold pleaded guilty to one count of dealing a controlled substance analogue. After a series of post-conviction proceedings, he re- ■ ceived a resentencing hearing and new sentence on December 14, 2015.

Newbold now appeals the sentence he received. He contends that his sentence is substantively unreasonable, and that the sentencing court failed to take into consideration his post-conviction conduct and medical needs. He also contends for the first time on appeal that his conviction should be vacated because, based on an intervening Supreme Court case, McFadden v. United States, — U.S. -, 135 S.Ct. 2298, 192 L.Ed.2d 260 (2015), the indictment, plea colloquy, and factual basis for the plea agreement failed to establish that he satisfied the knowledge element of the crime.

For the reasons below, we affirm New-bold’s conviction and sentence.

I.

In July 2005, Newbold was indicted for, among other crimes, one count of distributing a controlled substance analogue. He pleaded guilty in September 2005 to the distribution charge, as well as money laun-' dering and being a felon in possession of a firearm. At Newbold’s plea colloquy, the district judge asked Newbold if he understood that the government had to prove the following: that Newbold “willfully, knowingly, and intentionally distributed 5.3 grams of a mixture containing a detectable amount of 5-MeO-AMT, which is a controlled substance, and with the intent for human consumption; and that [he] knew that what [he] w[as] distributing was some kind of controlled substance.” J.A. 53. The prosecutor then clarified, and the judge accepted, that 5-MeO-AMT was a controlled substance analogue. Newbold then stipulated that there were enough facts for the court to determine that he fulfilled each of the crime’s elements. J.A. 60. The district judge also read aloud the plea agreement’s written factual basis, which stated that Newbold sold “fifty gel capsules containing a substance represented to be like ‘Ecstasy.’ ” J.A. 32.

Under then-binding precedent, United States v. Harp, 406 F.3d 242 (4th Cir. 2005), Newbold qualified for a sentencing enhancement on his firearm-possession charge under the Armed Career Criminal Act, and was sentenced to 225 months. He unsuccessfully appealed his sentence and then challenged his sentencing enhancement in protracted habeas proceedings. During the course of Newbold’s proceedings, we overruled Harp in United States v. Simmons, 649 F.3d 237 (4th Cir. 2011) (en banc). In March 2015, applying Simmons retroactively, see Miller v. United States, 735 F.3d 141 (4th Cir. 2013), we held that Newbold did not qualify for the armed-career-criminal sentencing enhancement, and we remanded his case for resen-tencing.

In June 2015, the Supreme Court issued McFadden, which clarified the knowledge element for the crime of distributing a controlled substance analogue. At the time of Newbold’s conviction, the government could satisfy this element by showing only that Newbold intended for the substance to be consumed by humans. United States v. Klecker, 348 F.3d 69, 71 (4th Cir. 2003). The McFadden Court, however, rejected that standard. It held that, to convict someone of dealing a controlled substance analogue, the government must also show that “the defendant knew that the substance was controlled under the [Controlled Substances Act] or the Analogue Act, even if he did not know its identity.” 135 S.Ct. at 2302.

*184 Newbold’s resentencing hearing occurred on December 14, 2015, The parties agreed that the proper Sentencing Guidelines range was 151 to 188 months. New-bold neither challenged his underlying conviction nor raised McFadden at his hearing. Instead, he requested only a downward variance to 143 months because of his chronic Hepatitis C and his post-conviction conduct. His statement included attachments from his physician indicating that he was nonresponsive to the treatment he received, Newbold’s request for a different treatment that he believed would be more effective, the prison’s denial of his request, a certificate from the prison’s law library for his work, and Newbold’s request that the judge increase his time at a Residential Recovery Center so he could receive medical treatment more quickly.

In support of his request for a downward variance, Newbold also emphasized his exemplary behavior while incarcerated. During the 10.5 years of his incarceration, he worked in the law library for seven years, receiving a commendation; had not failed a single alcohol or drug test; attended church, Bible, and music groups; played piano for eight years; was approved for minimum security; and had a stable home environment, including a wife, mother, and adult son to return to. The prosecutor, on the other hand, emphasized an infraction Newbold had received while incarcerated and the fact that Newbold’s current offense was his seventeenth drug conviction.

The judge ultimately denied the request for a downward variance and sentenced Newbold to 165 months, the middle of the applicable range. The judge considered Newbold’s Hepatitis C, including its severity, Newbold’s ability to receive his requested medication, and whether Newbold had exhausted the internal appeals process for requesting the medication. The judge also emphasized the seriousness of New-bold’s crimes and criminal history, and noted that he wanted the sentence to reflect the offense’s seriousness, promote respect for the law, and protect the public from potential future drug offenses. The judge stated the following:

[W]hy would somebody with your talents and abilities have even done this in the first place, and what have you learned, and why won’t you do it again? I still have some concern about that, and I hope that your sentence ... has caused you to appreciate the need to protect the public from polluting other people with these drugs that you are or were distributing.

J.A. 141. And lastly, the judge concluded, “I appreciate the problem with your Hepatitis C, and I hope that it holds off long enough so that when you are released, you can get whatever treatment you wish to get.” J.A. 146.

Newbold timely appeals his sentence and challenges his underlying conviction for the first time on appeal.

II.

We first examine Newbold’s challenge to his conviction, and then turn to his sentencing appeal.

A.

Relying on McFadden, Newbold argues that the indictment, plea colloquy, and factual basis for his plea agreement fail to show that he had sufficient knowledge of the elements of his crime to be convicted for dealing a controlled substance analogue. We first examine whether we are procedurally barred from reviewing New-bold’s claims.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Johnson v. Zerbst
304 U.S. 458 (Supreme Court, 1938)
Brady v. United States
397 U.S. 742 (Supreme Court, 1970)
Tollett v. Henderson
411 U.S. 258 (Supreme Court, 1973)
United States v. Young
470 U.S. 1 (Supreme Court, 1985)
Griffith v. Kentucky
479 U.S. 314 (Supreme Court, 1987)
Christianson v. Colt Industries Operating Corp.
486 U.S. 800 (Supreme Court, 1988)
United States v. Olano
507 U.S. 725 (Supreme Court, 1993)
Bousley v. United States
523 U.S. 614 (Supreme Court, 1998)
United States v. Cotton
535 U.S. 625 (Supreme Court, 2002)
Gall v. United States
552 U.S. 38 (Supreme Court, 2007)
United States v. Simmons
649 F.3d 237 (Fourth Circuit, 2011)
United States v. Strieper
666 F.3d 288 (Fourth Circuit, 2012)
United States v. George Robert Bell
5 F.3d 64 (Fourth Circuit, 1993)
United States v. Richard Lester Klecker
348 F.3d 69 (Fourth Circuit, 2003)
United States v. Johnny Craig Harp
406 F.3d 242 (Fourth Circuit, 2005)
United States v. Quiana Ganay Hampton
441 F.3d 284 (Fourth Circuit, 2006)
Bradshaw v. Stumpf
545 U.S. 175 (Supreme Court, 2005)
United States v. Newbold
215 F. App'x 289 (Fourth Circuit, 2007)
TFWS, Inc. v. Franchot
572 F.3d 186 (Fourth Circuit, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
686 F. App'x 181, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-joseph-newbold-ca4-2017.